MX2019014140A - Metodos de cultivo celular. - Google Patents

Metodos de cultivo celular.

Info

Publication number
MX2019014140A
MX2019014140A MX2019014140A MX2019014140A MX2019014140A MX 2019014140 A MX2019014140 A MX 2019014140A MX 2019014140 A MX2019014140 A MX 2019014140A MX 2019014140 A MX2019014140 A MX 2019014140A MX 2019014140 A MX2019014140 A MX 2019014140A
Authority
MX
Mexico
Prior art keywords
cell culture
culture methods
heterogeneity
proteins
antibodies
Prior art date
Application number
MX2019014140A
Other languages
English (en)
Inventor
Jeffrey Yates Andrew
Ben Yahia Bassem
Malphettes Laetitia
Kochanowski Nadine
Renner Gill
Durran Sandrine
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of MX2019014140A publication Critical patent/MX2019014140A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere al uso de cantidades limitadas de cisteína y triptófano en el medio de cultivo celular durante la producción de proteínas recombinantes, y en particular de anticuerpos. Las proteínas y anticuerpos producidos bajo tales condiciones controladas exhiben heterogeneidad reducida, en particular una heterogeneidad de variantes de carga reducida.
MX2019014140A 2017-05-31 2018-05-29 Metodos de cultivo celular. MX2019014140A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1708655.4A GB201708655D0 (en) 2017-05-31 2017-05-31 Cell culture methods
PCT/EP2018/064102 WO2018219968A1 (en) 2017-05-31 2018-05-29 Cell culture methods

Publications (1)

Publication Number Publication Date
MX2019014140A true MX2019014140A (es) 2020-02-07

Family

ID=59270991

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019014140A MX2019014140A (es) 2017-05-31 2018-05-29 Metodos de cultivo celular.

Country Status (17)

Country Link
US (1) US20200239923A1 (es)
EP (1) EP3630946B1 (es)
JP (3) JP7460370B2 (es)
KR (1) KR20200012972A (es)
CN (1) CN110741077A (es)
AU (1) AU2018276376A1 (es)
BR (1) BR112019024390A2 (es)
CA (1) CA3065661A1 (es)
CL (1) CL2019003459A1 (es)
CO (1) CO2019012871A2 (es)
EA (1) EA201992828A1 (es)
GB (1) GB201708655D0 (es)
IL (1) IL270880A (es)
MX (1) MX2019014140A (es)
MY (1) MY193535A (es)
RU (2) RU2758674C2 (es)
WO (1) WO2018219968A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201708655D0 (en) * 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
WO2022137132A1 (en) * 2020-12-22 2022-06-30 Novartis Ag Methods for reducing the oxidation level of cysteine residues in a secreted recombinantly-expressed protein during cell culture
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101523782B1 (ko) * 2006-11-08 2015-05-28 와이어쓰 엘엘씨 세포 배양을 위한 합리적으로 설계된 배지
US8030027B2 (en) * 2008-04-29 2011-10-04 St. Jude Children's Research Hospital Method for enhancing recombinant antibody production
CA2797140C (en) * 2010-04-26 2018-01-23 Novartis Ag Improved cell culture medium
US9133493B2 (en) * 2011-04-21 2015-09-15 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
EP2830658B1 (en) * 2012-03-26 2018-10-10 Sanofi Stable igg4 binding agent formulations
WO2013158275A1 (en) * 2012-04-20 2013-10-24 Abbvie Inc. Cell culture methods to reduce acidic species
GB201208370D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Antibodies
GB201208367D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
WO2014145091A1 (en) * 2013-03-15 2014-09-18 Genentech, Inc. Cell culture media and methods of antibody production
GB201508180D0 (en) * 2015-05-13 2015-06-24 Ucb Biopharma Sprl Antibodies
EP3448871B1 (en) * 2016-04-28 2023-10-11 Merck Patent GmbH Method for reducing the trisulfide level in proteins
GB201608323D0 (en) * 2016-05-12 2016-06-29 Ucb Biopharma Sprl Pharmaceutical compositions
WO2018018613A1 (zh) * 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods

Also Published As

Publication number Publication date
EP3630946A1 (en) 2020-04-08
RU2019143742A3 (es) 2021-06-30
MY193535A (en) 2022-10-18
EP3630946B1 (en) 2024-03-27
JP7460370B2 (ja) 2024-04-02
EA201992828A1 (ru) 2020-04-21
IL270880A (en) 2020-01-30
US20200239923A1 (en) 2020-07-30
RU2019143742A (ru) 2021-06-30
CL2019003459A1 (es) 2020-04-24
RU2021128024A (ru) 2021-12-08
WO2018219968A1 (en) 2018-12-06
JP2021185185A (ja) 2021-12-09
BR112019024390A2 (pt) 2020-07-14
GB201708655D0 (en) 2017-07-12
KR20200012972A (ko) 2020-02-05
EP3630946C0 (en) 2024-03-27
CA3065661A1 (en) 2018-12-06
RU2758674C2 (ru) 2021-11-01
AU2018276376A1 (en) 2019-12-12
CO2019012871A2 (es) 2020-01-17
CN110741077A (zh) 2020-01-31
JP7406593B2 (ja) 2023-12-27
JP2020521490A (ja) 2020-07-27
JP2022153421A (ja) 2022-10-12

Similar Documents

Publication Publication Date Title
PH12019501227A1 (en) Synthetic immune receptors and methods of use thereof
MX2020006117A (es) Integracion dirigida de acidos nucleicos.
MX2021008142A (es) Metodos para cosechar cultivos de celulas de mamifero.
MX2022003477A (es) Medio de cultivo celular complementado con taurina y metodos de uso.
MX2017005344A (es) Composiciones y metodos para reforzar la eficacia de inmunoterapia celular adoptiva.
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
MX2018014043A (es) Composiciones de cultivo celular con antioxidantes y metodos para la produccion de polipeptidos.
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
MX2023014077A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
MY193535A (en) Cell culture methods
MX2016011465A (es) Drimenol-sintasas y metodos para producir drimenol.
MX2021001981A (es) Metodos para preparar un poloxamero para usar en medio de cultivo celular.
EA201791233A1 (ru) Материал стволовых клеток и способ его получения
MX2016013955A (es) Drimenol-sintasas y metodo de produccion de drimenol.
MX2018003445A (es) Expresion de proteinas que contienen fc.
MX2015010887A (es) Formulaciones y metodos para aumentar la produccion de proteinas recombinantes.
WO2015117033A3 (en) Methods of increasing protein production in mammalian cells
MX2020002382A (es) Métodos y composiciones para mejorar la expresión de proteínas recombinantes.